Search

Search Constraints

You searched for: Author/Creator Han, Sang Youb

Search Results

8. Comparative efficacy and safety of gemigliptin versus linagliptin in type 2 diabetes patients with renal impairment: A 40‐week extension of the GUARD randomized study. Issue 2 (6th September 2017)